On the other hand, an additional in vitro study demonstrated that excessive O‐glycosylation of APP by GALNT6 led to a significant reduction in the generation of Aβ40, a variant of Aβ associated with AD pathology. This evidence concerns the gene APP and Alzheimer disease.